Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine
Herausgeber: Gussak, Ihor B.; Akin, Ibrahim; Kostis, John B.
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine
Herausgeber: Gussak, Ihor B.; Akin, Ibrahim; Kostis, John B.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers. Edited by two renowned cardiology experts, Iatrogenicity addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system.
Andere Kunden interessierten sich auch für
Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers. Edited by two renowned cardiology experts, Iatrogenicity addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system.
Produktdetails
- Produktdetails
- Verlag: Rutgers University Press
- None
- Seitenzahl: 448
- Altersempfehlung: ab 21 Jahre
- Erscheinungstermin: 15. Dezember 2017
- Englisch
- Abmessung: 254mm x 102mm x 19mm
- Gewicht: 762g
- ISBN-13: 9780813590400
- ISBN-10: 081359040X
- Artikelnr.: 46511554
- Verlag: Rutgers University Press
- None
- Seitenzahl: 448
- Altersempfehlung: ab 21 Jahre
- Erscheinungstermin: 15. Dezember 2017
- Englisch
- Abmessung: 254mm x 102mm x 19mm
- Gewicht: 762g
- ISBN-13: 9780813590400
- ISBN-10: 081359040X
- Artikelnr.: 46511554
IHOR GUSSAK, MD, PhD, FACC, is a clinical professor of medicine at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson, and executive editor of the Journal of Electrocardiology. JOHN B. KOSTIS, MD, FACP, FACC, is the John G. Detwiler Professor of Cardiology, professor of medicine and pharmacology, and associate dean for cardiovascular research at the University of Medicine and Dentistry of New Jersey. He is also the director of the Cardiovascular Institute at Robert Wood Johnson Medical School in New Brunswick, New Jersey.
TABLE OF CONTENTS
Part I: MEDICAL HARM
1. The Concept and Spectrum of "Iatrogenicity"
I. Gussak and J. Kostis
2. Iatrogenicity: Definition, History and Modern Context
M. Gussak, I. Gussak, and J. Kostis
3. Epidemiology and Public Health Aspects and Implications:
Regulatory, Legal and Ethical Dimensions of Iatrogenicity
S. Jones and M. Gonzalez
4. Risk Management: The Medical Center Administration Perspective
S. Jones and M. Gonzalez
5. Iatrogenicity from the Patient's Perspective
J. Dobrzynski, S. Jones, and M. Gonzalez
6. A Naturopathic Perspective on Iatrogenesis
C. Fleetwood
Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY
OF NON-CARDIAC DRUGS
7. Clinical Manifestations of Acute and Chronic Drug-Induced
Iatrogenic Cardiovascular Diseases and Syndromes
I. Gussak, G. Yan, A. Jahangir, and J. Kostis
8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
A. Narichania, Y. Yokoyama, and W.K. Shen
9. Chemotherapy-Induced Cardiomyopathies
E. Birati and B. Jessup
10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of
Hypertension
T. Giles, G. Sander, I. Gussak, and J. Kostis
11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes
R. Kalaitzidis and G. Bakris
12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and
Non-Cardiac Toxicities: Antihypertensive Agents and Biologics
E. Hermes-Desantis and J. Barone
13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
C. Thomopoulos and T. Makris
14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as
the Prime Suspect
G. Bachmann, M. Rees, and N. Phillips
15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic,
Antiplatelet, and Antithrombotic Agents
C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis
16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System
K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas
17. Iatrogencity and Antianginal Drugs
A. Moreyra and W.J. Kostis
18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand?
R. Kumar
19. Cardiovascular Iatrogenicity in Older Adults
A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #.
Malone
Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND
NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES
20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in
Interventional Cardiology
C. Dösch, D. Loßnitzer, T. Papavassiliu
21. Iatrogenicity Associated with Interventional Treatment Modalities
N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta
22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive
Cardiovascular Interventions, Devices and Surgeries
M. Behnes, T. Becher, S. Baumann, and I. Akin
23. Iatrogenic Aspects in Cardiac Electrophysiology
B. Rudic, E. Tülümen, and V. Liebe
24. Iatrogenic Aspects in Cardiac Device Therapy
S. Röger and J. Kuschyk
25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities
M.S. Nolledo, P. Lerma and T.V. Santiago
Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE
MODIFICATIONS
26. Professional Athletes
G. Mancia
27. Sports Cardiology
G. Campanile
28. Dangers of Lifestyle Modification Advice
G. Campanile
Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER
NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE
29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:
Side-effects and Contraindications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
30. Interactions Between Supplements and Prescription Medications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
Acknowledgments
Index
Part I: MEDICAL HARM
1. The Concept and Spectrum of "Iatrogenicity"
I. Gussak and J. Kostis
2. Iatrogenicity: Definition, History and Modern Context
M. Gussak, I. Gussak, and J. Kostis
3. Epidemiology and Public Health Aspects and Implications:
Regulatory, Legal and Ethical Dimensions of Iatrogenicity
S. Jones and M. Gonzalez
4. Risk Management: The Medical Center Administration Perspective
S. Jones and M. Gonzalez
5. Iatrogenicity from the Patient's Perspective
J. Dobrzynski, S. Jones, and M. Gonzalez
6. A Naturopathic Perspective on Iatrogenesis
C. Fleetwood
Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY
OF NON-CARDIAC DRUGS
7. Clinical Manifestations of Acute and Chronic Drug-Induced
Iatrogenic Cardiovascular Diseases and Syndromes
I. Gussak, G. Yan, A. Jahangir, and J. Kostis
8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
A. Narichania, Y. Yokoyama, and W.K. Shen
9. Chemotherapy-Induced Cardiomyopathies
E. Birati and B. Jessup
10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of
Hypertension
T. Giles, G. Sander, I. Gussak, and J. Kostis
11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes
R. Kalaitzidis and G. Bakris
12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and
Non-Cardiac Toxicities: Antihypertensive Agents and Biologics
E. Hermes-Desantis and J. Barone
13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
C. Thomopoulos and T. Makris
14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as
the Prime Suspect
G. Bachmann, M. Rees, and N. Phillips
15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic,
Antiplatelet, and Antithrombotic Agents
C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis
16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System
K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas
17. Iatrogencity and Antianginal Drugs
A. Moreyra and W.J. Kostis
18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand?
R. Kumar
19. Cardiovascular Iatrogenicity in Older Adults
A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #.
Malone
Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND
NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES
20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in
Interventional Cardiology
C. Dösch, D. Loßnitzer, T. Papavassiliu
21. Iatrogenicity Associated with Interventional Treatment Modalities
N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta
22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive
Cardiovascular Interventions, Devices and Surgeries
M. Behnes, T. Becher, S. Baumann, and I. Akin
23. Iatrogenic Aspects in Cardiac Electrophysiology
B. Rudic, E. Tülümen, and V. Liebe
24. Iatrogenic Aspects in Cardiac Device Therapy
S. Röger and J. Kuschyk
25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities
M.S. Nolledo, P. Lerma and T.V. Santiago
Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE
MODIFICATIONS
26. Professional Athletes
G. Mancia
27. Sports Cardiology
G. Campanile
28. Dangers of Lifestyle Modification Advice
G. Campanile
Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER
NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE
29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:
Side-effects and Contraindications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
30. Interactions Between Supplements and Prescription Medications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
Acknowledgments
Index
TABLE OF CONTENTS
Part I: MEDICAL HARM
1. The Concept and Spectrum of "Iatrogenicity"
I. Gussak and J. Kostis
2. Iatrogenicity: Definition, History and Modern Context
M. Gussak, I. Gussak, and J. Kostis
3. Epidemiology and Public Health Aspects and Implications:
Regulatory, Legal and Ethical Dimensions of Iatrogenicity
S. Jones and M. Gonzalez
4. Risk Management: The Medical Center Administration Perspective
S. Jones and M. Gonzalez
5. Iatrogenicity from the Patient's Perspective
J. Dobrzynski, S. Jones, and M. Gonzalez
6. A Naturopathic Perspective on Iatrogenesis
C. Fleetwood
Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY
OF NON-CARDIAC DRUGS
7. Clinical Manifestations of Acute and Chronic Drug-Induced
Iatrogenic Cardiovascular Diseases and Syndromes
I. Gussak, G. Yan, A. Jahangir, and J. Kostis
8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
A. Narichania, Y. Yokoyama, and W.K. Shen
9. Chemotherapy-Induced Cardiomyopathies
E. Birati and B. Jessup
10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of
Hypertension
T. Giles, G. Sander, I. Gussak, and J. Kostis
11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes
R. Kalaitzidis and G. Bakris
12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and
Non-Cardiac Toxicities: Antihypertensive Agents and Biologics
E. Hermes-Desantis and J. Barone
13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
C. Thomopoulos and T. Makris
14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as
the Prime Suspect
G. Bachmann, M. Rees, and N. Phillips
15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic,
Antiplatelet, and Antithrombotic Agents
C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis
16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System
K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas
17. Iatrogencity and Antianginal Drugs
A. Moreyra and W.J. Kostis
18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand?
R. Kumar
19. Cardiovascular Iatrogenicity in Older Adults
A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #.
Malone
Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND
NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES
20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in
Interventional Cardiology
C. Dösch, D. Loßnitzer, T. Papavassiliu
21. Iatrogenicity Associated with Interventional Treatment Modalities
N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta
22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive
Cardiovascular Interventions, Devices and Surgeries
M. Behnes, T. Becher, S. Baumann, and I. Akin
23. Iatrogenic Aspects in Cardiac Electrophysiology
B. Rudic, E. Tülümen, and V. Liebe
24. Iatrogenic Aspects in Cardiac Device Therapy
S. Röger and J. Kuschyk
25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities
M.S. Nolledo, P. Lerma and T.V. Santiago
Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE
MODIFICATIONS
26. Professional Athletes
G. Mancia
27. Sports Cardiology
G. Campanile
28. Dangers of Lifestyle Modification Advice
G. Campanile
Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER
NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE
29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:
Side-effects and Contraindications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
30. Interactions Between Supplements and Prescription Medications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
Acknowledgments
Index
Part I: MEDICAL HARM
1. The Concept and Spectrum of "Iatrogenicity"
I. Gussak and J. Kostis
2. Iatrogenicity: Definition, History and Modern Context
M. Gussak, I. Gussak, and J. Kostis
3. Epidemiology and Public Health Aspects and Implications:
Regulatory, Legal and Ethical Dimensions of Iatrogenicity
S. Jones and M. Gonzalez
4. Risk Management: The Medical Center Administration Perspective
S. Jones and M. Gonzalez
5. Iatrogenicity from the Patient's Perspective
J. Dobrzynski, S. Jones, and M. Gonzalez
6. A Naturopathic Perspective on Iatrogenesis
C. Fleetwood
Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY
OF NON-CARDIAC DRUGS
7. Clinical Manifestations of Acute and Chronic Drug-Induced
Iatrogenic Cardiovascular Diseases and Syndromes
I. Gussak, G. Yan, A. Jahangir, and J. Kostis
8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
A. Narichania, Y. Yokoyama, and W.K. Shen
9. Chemotherapy-Induced Cardiomyopathies
E. Birati and B. Jessup
10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of
Hypertension
T. Giles, G. Sander, I. Gussak, and J. Kostis
11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes
R. Kalaitzidis and G. Bakris
12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and
Non-Cardiac Toxicities: Antihypertensive Agents and Biologics
E. Hermes-Desantis and J. Barone
13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
C. Thomopoulos and T. Makris
14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as
the Prime Suspect
G. Bachmann, M. Rees, and N. Phillips
15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic,
Antiplatelet, and Antithrombotic Agents
C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis
16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System
K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas
17. Iatrogencity and Antianginal Drugs
A. Moreyra and W.J. Kostis
18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand?
R. Kumar
19. Cardiovascular Iatrogenicity in Older Adults
A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #.
Malone
Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND
NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES
20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in
Interventional Cardiology
C. Dösch, D. Loßnitzer, T. Papavassiliu
21. Iatrogenicity Associated with Interventional Treatment Modalities
N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta
22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive
Cardiovascular Interventions, Devices and Surgeries
M. Behnes, T. Becher, S. Baumann, and I. Akin
23. Iatrogenic Aspects in Cardiac Electrophysiology
B. Rudic, E. Tülümen, and V. Liebe
24. Iatrogenic Aspects in Cardiac Device Therapy
S. Röger and J. Kuschyk
25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities
M.S. Nolledo, P. Lerma and T.V. Santiago
Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE
MODIFICATIONS
26. Professional Athletes
G. Mancia
27. Sports Cardiology
G. Campanile
28. Dangers of Lifestyle Modification Advice
G. Campanile
Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER
NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE
29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:
Side-effects and Contraindications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
30. Interactions Between Supplements and Prescription Medications
S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A.
Jahangir
Acknowledgments
Index